Clinical Trials Logo

Constriction, Pathologic clinical trials

View clinical trials related to Constriction, Pathologic.

Filter by:

NCT ID: NCT05673525 Not yet recruiting - Aortic Stenosis Clinical Trials

A Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis

Start date: December 30, 2022
Phase: N/A
Study type: Interventional

A Clinical Trial of the Transcatheter Aortic Valve Implantation System with a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients with Severe Aortic Stenosis

NCT ID: NCT05672836 Not yet recruiting - Clinical trials for Aortic Valve Stenosis

ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

ENAVO-TAVR
Start date: December 2023
Phase: Phase 4
Study type: Interventional

The goal of this trial is to determine whether the use of a novel SGLT2 inhibitor(Sodium-glucose Cotransporter-2), Enavogliflozin is safe and effective for the improvement of adverse clinical outcomes and the reversal of adverse cardiac remodelling among patients who had undergone TAVR as compared with the standard-of-care therapy.

NCT ID: NCT05667285 Enrolling by invitation - Clinical trials for Native Coronary Artery Stenosis

BIOFLOW-china Post-marketing Study (BIOTRONIK)

Start date: May 26, 2023
Phase:
Study type: Observational

This trial uses prospective, retrospective, observational, non-blinded, multi-center, single-arm, post-marketing hospital data collection and research methods. The goal of this study is to assess the safety of BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System in the Chinese patient population after marketing in China.

NCT ID: NCT05666388 Completed - Thrombosis Clinical Trials

Rescue Stenting in the Severe Atherosclerotic Stenosis After the Failure of Intravenous Thrombolysis

RESFIT
Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Intravenous (IV) recombinant tissue plasminogen activator is the standard of care for patients with acute ischemic stroke (AIS) who present to the hospital within 4.5 hours of symptom onset. However, IV thrombolysis, even bridging thrombolysis (combining intravenous thrombolysis and mechanical thrombectomy) has limited efficacy among patients who had occlusive lesions associated with highgrade arterial stenosis requiring revascularization to improve neurological deficits. The investigators evaluated whether rescue stenting results in good outcomes among patients after the failure of intravenous thrombolysis and bridging thrombolysis.

NCT ID: NCT05653505 Not yet recruiting - Clinical trials for Ischemic Preconditioning

Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic Stenosis

Start date: January 1, 2023
Phase:
Study type: Observational [Patient Registry]

The purpose of this registry is to evaluate the safety and efficacy of RIC for patients with symptomatic intracranial atherosclerotic stenosis (sICAS) undergoing endovascular therapy.

NCT ID: NCT05651165 Recruiting - Clinical trials for Popliteal Arterial Stenosis

Drug-Eluting Balloons vs Mimetic Stents for Popliteal Artery Disease

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

More advanced and severe cases of chronic lower limb ischemia (the so-called critical lower limb ischemia) are painful and limiting conditions that impact on patients' quality of life. Until now, the available evidence for the femoropopliteal area only defines open surgery or endovascular treatment indications. However, the best strategy for endovascular procedures is still unclear. The popliteal artery is a challenging anatomical site for balloon angioplasty alone and standard nitinol stenting angioplasty. This randomized clinical trial aims to assess the superiority of nitinol stent angioplasty compared to pharmacoactive balloon angioplasty to treat critical lower limb ischemia due to popliteal artery arteriosclerosis.

NCT ID: NCT05646381 Recruiting - Aortic Stenosis Clinical Trials

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Start date: March 7, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) administered subcutaneously once monthly compared to placebo in slowing the progression of calcific aortic valve stenosis.

NCT ID: NCT05645497 Recruiting - Clinical trials for Degenerative Lumbar Spinal Stenosis

Evaluation of the Efficacy and Safety of the FACET FIXation Implant.

FACETFIX
Start date: January 17, 2023
Phase:
Study type: Observational

This is a single center, hybrid retrospective and prospective (ambispective) study to evaluate the safety and efficacy of the Facet Fixation implant. The main objective is to evaluate the efficacy of the Facet Fixation implant compared with pedicle screw fixation to determine successful fusion in radiographic assessment at more than two years. Fusion is mainly defined as any sign of bony fusion between the facet joints or transverse processes when viewing the postoperative CT-scan at over 2 years.

NCT ID: NCT05644314 Recruiting - Ischemic Stroke Clinical Trials

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, open-access, single-arm trial to observe the real-world clinical efficacy of drug-eluting vertebral artery stenting system treatment for Atherosclerotic Vertebral Arteries Stenosis. Patients will be followed at 30 days, 6, and 12 months post-procedure and annually for 1 year within 3 years.

NCT ID: NCT05641584 Completed - Inflammation Clinical Trials

Is Monocyte/HDL Ratio a Predictor of Mortality in Aortic Valve Surgery

Start date: May 10, 2022
Phase:
Study type: Observational

In this study, the investigators aimed to determine whether the preoperative Monocyte/HDL ratio would be a predictor of postoperative mortality and morbidity in patients who underwent aortic valve replacement due to aortic stenosis.